• Profile
Close

Benefits and harms of aspirin desensitization for aspirin-exacerbated respiratory disease: A systematic review and meta-analysis

International Forum of Allergy & Rhinology Sep 21, 2019

Chu DK, et al. - As aspirin desensitization is increasingly recommended to treat aspirin-exacerbated respiratory disease (AERD), researchers conducted this systematic review to test the safety and efficacy of aspirin desensitization (mean daily dose 800 mg) in patients (n = 233) with AERD. From inception to January 5, 2019, MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and World Health Organization (WHO) International Clinical Trials Registry Platform were searched. According to findings, moderate-certainty and high-certainty evidence in patients with AERD indicates that aspirin desensitization meaningfully decreases symptoms of rhinosinusitis and improves quality of life, but results in a significant increase in adverse events like major bleeding, gastritis, asthma exacerbation, or rash causing drug discontinuation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay